The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I reckon we would have closer at 6p if not for that RNS.
What makes it worse is the Stroke news by NICE was due I believe in September and now we are in March and FDA partner news was due end of December or early next year if I remember correctly. James Cheek makes meeting deadlines look impossible. Imagine someone saying you have to do this in a month and many months later we have no news on it. That is what James Cheek has done. No wonder it kept dropping as the CEO has lied so much.
Mean a few hundred thousand shares sold later that is. I never seen a stock so manipulated. Weeks there has been like 400 buys and 30 sells and it dropped like 2p.
I think Genedrive the only stock that seems to crash everyday with more reported buys than sells. I know it could be reported wrongly but still it seems to be the case every trading day. I think one week it went to 8p recently after millions of shared bought. A few hundred shares sold later it was 4p.
Just hope we get some good news soon.
Its got to the point I will take the 12-13p it was when James Cheek arrived. I believed he was the real deal when I saw his profile and the fact he said he is here to improve the share price. I didn’t know his job was just to crash the share price. I reckon if James Cheek left it would double.
Surely it is illegal to promise news by a certain date and be months out?
James Cheek lied then about multiple pieces of news due by now and today was the reason he was waiting to crash it.
James Cheek was brought into improve the share price but all he has done is crash it.
Leak? Random but I haven’t seen buying like this for a while.
Buys and sells are not accurate on LSE.
Roger65 makes sledgey121 and starres look like rampers.
I was expecting FDA partner news by now.
Looks better.
I have to say this has put me into depression. :(
I was expecting big news around December and January.
Https://www.westminsterforumprojects.co.uk/conference/NICE-2024
The share price was 12-13p when James Cheek was brought in to improve the share price. Now 4.125. Its got to the point I would take 20p now.
I noticed RF done the same to Sareum as well. I think if RF were removed with alternative financing, this would rocket back into the 30’s.